Louis Moore Bacon's ANGO Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 195,503 shares of AngioDynamics, Inc. (ANGO) worth $2.22 M, representing 0.05% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in ANGO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 147,324 shares. Largest reduction occurred in Q4 2025, reducing 71,728 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's AngioDynamics (ANGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly AngioDynamics (ANGO) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +29,267 | Add 17.61% | 195,503 | $11.37 |
| Q4 2025 | -71,728 | Reduce 30.14% | 166,236 | $12.84 |
| Q3 2025 | +147,324 | Add 162.54% | 237,964 | $11.17 |
| Q2 2025 | +634 | Add 0.70% | 90,640 | $9.92 |
| Q1 2025 | +90,006 | New Buy | 90,006 | $9.39 |
Louis Moore Bacon's AngioDynamics Investment FAQs
Louis Moore Bacon first purchased AngioDynamics, Inc. (ANGO) in Q1 2025, acquiring 90,006 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held AngioDynamics, Inc. (ANGO) for 5 quarters since Q1 2025.
Louis Moore Bacon's largest addition to AngioDynamics, Inc. (ANGO) was in Q3 2025, adding 237,964 shares worth $2.66 M.
According to the latest 13F filing for Q1 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 195,503 shares of AngioDynamics, Inc. (ANGO), valued at approximately $2.22 M.
As of the Q1 2026 filing, AngioDynamics, Inc. (ANGO) represents approximately 0.05% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in AngioDynamics, Inc. (ANGO) was 237,964 shares, as reported at the end of Q3 2025.